Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ACTRN12626000410358) titled 'The efficacy of vitamin B12 in reducing ocular signs and symptoms of dry eye disease' on April 2.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Masking: Blinded (masking used)
Assignment: Parallel
Type of endpoint: Efficacy
Primary Sponsor: University of New South Wales Sydney
Condition:
Dry eye disease
Dry eye disease
Eye - Diseases / disorders of the eye
Intervention:
Oral vitamin B12 supplement:
-Mecobalamin 1000 microgram, once daily.
-3 months administration.
-Compliance will be monitored by counting the dispensed and returned capsules and bott...